PETG Medical Tray Manufacturers: 10 Suppliers for 2026

Technology and applications

A medical tray usually begins as sheet heated and formed against a tool. Trimming establishes the outline and flange; formed pockets locate the device and can organize a kit for use. The same broad process serves a transport carrier, a protective insert and a component of a sterile barrier system. The required evidence depends on which of those roles the tray performs.

For terminally sterilized devices, ISO 11607-1 addresses materials, sterile barrier systems and packaging systems. ISO 11607-2 addresses validation of the processes used to form, seal and assemble them. Material selection and process validation therefore belong in the same development schedule. An empty tray supplied to a device manufacturer may be only one element of the final system.

The package architecture establishes where responsibilities meet. A single tray with a sealed lid, nested trays and a tray inside another sterile barrier create different loading and opening sequences. The specification should name the barrier, protective packaging, lid construction and sealing operation. A written allocation of responsibilities is especially valuable when forming, device loading and sterilization take place at different companies.

Device retention also affects how the package is opened. Deep clips may hold a component firmly during shipping yet make it awkward to remove. Sharp edges can contact a tray wall or lid as the package flexes. A physical review with representative devices reveals these interactions more clearly than a rendering. It should include the intended opening direction, accessible grip areas and the order in which kit components are removed.

Materials and process control

PETG is glycol-modified polyethylene terephthalate. The grade, sheet formulation and construction need to be identified in the purchase specification. Clear appearance alone cannot distinguish an approved PETG from another polyester or establish equivalent performance after processing and storage.

Eastman's sterilization guidance for Eastar 6763 supports appropriately controlled ethylene oxide, gamma and electron-beam processing for that copolyester. It also warns that excessive temperature, humidity, energy exposure or dwell can affect package properties. These are grade-specific processing considerations, not a universal sterilization approval for PETG. Steam-autoclave suitability must not be inferred from compatibility with EtO or radiation. The packaging team needs evidence for the actual cycle, material and completed package.

Forming redistributes the sheet. The starting gauge describes incoming material; the wall beside a deep pocket or retention feature can be substantially different. The drawing should identify regions where thickness affects protection, retention or puncture resistance. Measurements from production-representative trays can then establish whether those regions meet the agreed criteria.

The flange is a functional interface with the lid and sealing equipment. Its width, condition and flatness deserve explicit requirements, along with handling practices that protect it before sealing. A tray can hold a device correctly and still create difficulty on the packaging line if the flange does not sit properly in the sealing fixture.

Trays also arrive in stacks. Denesting behavior, orientation and the way operators handle empty trays affect line performance. A trial using a realistic stack can expose sticking or awkward separation before a large order is placed. Changes to geometry, additives or surface treatments that improve feeding belong under the same approval process as other material and design changes.

Supplier selection and quality

A useful qualification plan separates three questions: whether the device fits, whether the manufacturing process produces the specified tray, and whether the completed packaging system performs as required. Each question needs appropriate samples and an identifiable approval record. A fit prototype may answer the first while leaving the other two open.

Production samples should be traceable to the tool, sheet specification, site and drawing revision. If prototype tooling or a different forming route was used, the development record should explain the differences. This avoids treating an early sample as evidence for a process it never experienced.

Environmental requirements need similar precision. Cleanroom classification, quality-system certification and sterility describe different matters. Procurement needs the named facility and the operations covered by the proposed controls, including any work after the tray leaves the forming area. The required handling and bagging conditions follow from the package specification; they cannot be established by a supplier's general medical-market description.

Package evaluation then considers the intended sterilization, distribution and shelf-life conditions under the device manufacturer's approved protocol. Seal strength and package integrity answer different questions and should not be collapsed into one generic “seal test.” The responsible packaging team selects the methods, sample plan and acceptance criteria for the particular construction.

Change control keeps that approved construction identifiable. Relevant changes can include sheet formulation, tool repairs, forming conditions, subcontracted work and production location. The supply agreement should identify who receives notification and who decides whether additional evidence is needed. A brief decision record covering the selected design and material helps later reviewers understand why an apparently small substitution matters.

For an existing tray transfer, access to tooling alone rarely describes the full task. The receiving team also needs drawings, material identification, inspection requirements and available process history. Gaps in those records become explicit transfer activities with owners and deliverables.

Costs and procurement

The price comparison becomes meaningful once all bidders quote the same package boundary. One offer may include tray design and tooling; another may also include protective inserts, lids, sealing development or qualification support. A common scope sheet makes those differences visible before unit prices drive the decision.

A focused enquiry contains:

• Device CAD, physical samples, variants and restricted contact surfaces.
• The proposed tray arrangement, lid, sealing interface and sterilization route.
• Material identification, critical dimensions and environmental requirements.
• Development stages, sample purposes and required documentation.
• Forecasts, release quantities, packing format and delivery location.
• Tool ownership, maintenance, approved changes and transfer deliverables.

Development costs include prototypes, tools, fixtures and engineering iterations. Recurring costs include the formed tray, other package components, inspection, delivery packing and freight. Later expenses can arise from revisions, duplicate tooling or transfer support. Quoting those items separately gives purchasing a basis for evaluating changes without reopening the entire program.

Demand assumptions deserve particular attention during a medical-device launch. A slower ramp, smaller releases or an additional variant can affect sheet purchasing and production scheduling. Supplier responses to those scenarios are more useful than an unsupported industry lead time or savings percentage. The agreed launch plan should also allow time for sample review and document delivery, since those dependencies can govern commercial release as much as tray production does.

Frequently asked questions

Does medical-grade PETG make a package sterile?

No. PETG is a material choice. Sterility and maintenance of the sterile barrier depend on the completed packaging system, sterilization process and relevant validation. The tray supplier's material documents support that work but cannot establish the performance of a package assembled and sealed elsewhere.

Can a PETG tray use any sterilization method?

Compatibility is specific to the grade and processing conditions. EtO or radiation data does not establish steam-autoclave suitability. The selected sterilization route should be considered before the material and package design are frozen, with the completed construction assessed under the intended exposure conditions.

Can APET replace PETG without a new review?

A substitution requires review by the responsible packaging team. Similar clarity and initial fit do not establish equivalent aging, sterilization or mechanical behavior. Eastman's PETG and APET study illustrates why results must be tied to particular materials and conditions; it does not qualify every available grade.

When are physical device samples needed?

CAD supports early geometry and pricing work. Physical samples become important when retention, sharp contacts, loading or removal must be assessed. The development plan should identify which approvals depend on representative devices and which dimensions remain provisional until those samples are available.

Related supplier guides

For device components, see medical cleanroom injection molding companies. For electronic assemblies moving through production, compare ESD thermoformed tray manufacturers; their electrical handling requirements differ from the final medical package specification.

Image credit

Photo: Dordan. Lighting and background adjusted; product geometry retained.